- Home
- / Konruns Pharmaceutical
Konruns Pharmaceutical
Stock Price
¥23.8
2024-10-29
Market Capitalization
¥3.7 B
2024-10-29
Revenue
¥903.4 M
FY, 2025
Konruns Pharmaceutical Summary
Company Summary
- Overview
- Konruns Pharmaceutical (北京康辰药业股份有限公司) is a company that manufactures and distributes pharmaceutical products. It engages in the development of drug candidates including CX1026, CX1003, and KC1036.
- Type
- Public
- Status
- Active
- Founded
- 2003
- Website
- http://www.konruns.cn
- Cybersecurity rating
Table of Contents
Konruns Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥212.0M
- Gross profit (Q1, 2026)
- ¥190.1M
- Net income (Q1, 2026)
- ¥48.5M
- Cash (Q1, 2026)
- ¥357.4M
- EBIT (Q1, 2026)
- ¥58.0M
- Enterprise value
- $3.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026